Drug Type Small molecule drug |
Synonyms OxyADF, Oxycodone HCl/niacin, Oxycodone/niacin + [2] |
Target |
Action agonists |
Mechanism Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC18H22ClNO4 |
InChIKeyMUZQPDBAOYKNLO-RKXJKUSZSA-N |
CAS Registry124-90-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | NDA/BLA | United States | - | |
Pain | NDA/BLA | - | - | |
Opioid-Related Disorders | Phase 2 | United States | 01 Mar 2008 |